Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune ...

The idea that a high salary correlates with high stress is a classic misconception. Thankfully, many satisfying careers offer ...

Genetically engineering bacteria that live on our skin could prevent frostbite and hypothermia in extreme environments ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Melius MicroBiomics receives Australian Dealings Involving Intentional Release licence as key step toward clinical evaluation: Vancouver, BC Thursday, March 19, 2026, 18:00 Hrs [I ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

Scientists have built functional cancer-fighting immune cells directly inside living animals, skipping the expensive and time-consuming process of extracting a patient’s cells and engineering them in ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has entered into a ...

The new film probes the possibility of alien life – here's how the science of Project Hail Mary stacks up.